Meta‐Analysis of Cardiorespiratory Fitness Impairment in Pediatric Heart Transplant Recipients Authors: Nadeen Wu, Stephen J. Foulkes, Nathan R. Weeldreyer, Calvin Kruger, Corey R. Tomczak, Michael Khoury, Jennifer L. Conway, Mark J. Haykowsky Published: 2026 ABSTRACT ABSTRACTPediatric heart transplant (PHTR) recipients have reduced cardiorespiratory fitness (VO2peak); however, the magnitude of this impairment and its underlying central hemodynamic mechanisms remain poorly characterized. This systematic review and meta‐analysis quantified differences in VO2peak and peak exercise central hemodynamics between PHTR recipients and age‐matched healthy controls (CON). MEDLINE (PubMed) was searched for studies comparing VO2peak in PHTR recipients and CON. Pooled effect sizes were expressed as weighted mean differences (WMD) using a DerSimonian–Laird random‐effects model, and weighted least‐squares meta‐regression assessed the moderating effects of age and time post‐transplant. Seven unique studies (PHTR n = 90; CON n = 118) reported VO2peak and peak HR. PHTR had significantly lower VO2peak (WMD = −9.5 mL/kg/min), peak HR (WMD: −30 bpm), and CO (n = 3 studies, WMD: −2.5 L/min), with no difference in peak SBP (n = 3 studies). Meta‐regression revealed no significant moderating effect of age or time post‐transplant on the VO2peak deficit. The markedly reduced VO2peak in PHTR recipients is driven primarily by impaired peak CO and persistent chronotropic incompetence, consistent with cardiac allograft sympathetic denervation. Introduction Heart transplantation is a life‐saving intervention for children and adolescents with end‐stage, treatment‐refractory heart failure. Despite improved long‐term survival after pediatric heart transplantation (PHTR), morbidity and reduced health‐related quality of life remain ongoing concerns [1]. Cardiorespiratory fitness—assessed by peak exercise oxygen uptake (VO2peak)—is a key determinant of long‐term outcomes in PHTR recipients [2]. Notably, VO2peak has been associated with cardiac sympathetic denervation, which is independently linked to poorer survival and retransplantation [2]. Prior research demonstrates that PHTR recipients have reduced VO2peak compared with age‐matched healthy controls (CON); however, the magnitude of this reduction varies widely across studies, potentially reflecting differences in participant age and time post transplantation [3]. Consequently, both the degree of VO2peak impairment and the contributions of central hemodynamic determinants, particularly peak exercise heart rate (HR) and cardiac output (CO), remain incompletely understood. To address these knowledge gaps, we conducted a systematic review and meta‐analysis to quantify differences in VO2peak (primary outcome) and peak exercise central hemodynamics between PHTR recipients and age‐matched healthy CON. Methods This systematic review and meta‐analysis was registered with PROSPERO (CRD420261290855). We searched MEDLINE (via PubMed) from its inception to the present using the following strategy: (pediatric OR child OR adolescent OR infant) AND (“heart transplant” OR “cardiac transplant”) AND (“exercise capacity” OR “cardiorespiratory fitness” OR “VO2peak” OR “peak oxygen consumption” OR “exercise test”). Effect sizes were calculated as Weighted Mean Differences (WMD) in original measurement units (PHTR minus CON). Studies were eligible if they reported VO2peak data for PHTR recipients alongside an age‐matched healthy control group. Pooled estimates were generated using the DerSimonian–Laird random‐effects model to account for between‐study heterogeneity (τ2). Weighted least‐squares meta‐regression examined the moderating effects of mean participant age and time post‐transplant on VO2peak. Study quality was assessed by two reviewers (NW, MH) using the Newcastle–Ottawa Scale. Results Ninety‐two citations were screened by title and abstract; seven unique studies reported VO2peak and peak exercise heart rate HR [4, 5, 6, 7, 8, 9, 10], and three of these also measured peak exercise cardiac output (CO) and systolic blood pressure (SBP) [4, 6, 10]. Exercise testing used cycle ergometry (n = 5 studies) and treadmill protocols (n = 2 studies). All included studies were rated as ‘good’ quality (Newcastle‐Ottawa scale score: 8/10). Across studies, 208 participants were included (90 PHTR, 118 CON). Groups were well matched for age (mean: PHTR 12.3 years; CON 12.8 years) and sex (65% male in both groups). Among PHTR recipients, the weighted mean time since transplant at the time of exercise testing was 6.3 years (range 2.0–12.0 years). Meta‐analysis demonstrated that PHTR recipients had a significantly lower VO2peak than CON (WMD = −9.53 mL/kg/min; 95% CI: −14.98 to −4.07; p = 0.0006; I2 = 87%, Figure 1A). They also exhibited substantially lower peak exercise HR (WMD = −30 bpm; 95% CI: −41 to −19; p < 0.0001; I2 = 83%; Figure 1B) and reduced peak CO (WMD = −2.47 L/min; 95% CI: −4.17 to −0.76; p = 0.005; I2 = 43%; Figure 1C). Peak SBP did not differ between groups (WMD = −0.2 mmHg; p = 0.98; Figure 1C). Forest plot of the weighted mean difference (WMD) in (A) VO2peak (mL/kg/min), (B) peak heart rate, and (C) peak CO (L/min) between pediatric heart transplant (PHTR) recipients and age‐matched healthy controls (CON). Meta‐regression showed that neither mean participant age (β = −1.30 mL/kg/min per year, p = 0.27) nor mean time post‐transplant (β = +1.07 mL/kg/min per year, p = 0.15) significantly moderated the VO2peak deficit. Funnel plot inspection suggested some asymmetry for VO2peak. Discussion The principal finding of this study is that, compared with age‐matched CON, PHTR recipients have a significant and clinically meaningful reduction in VO2peak (−9.5 mL/kg/min), peak exercise CO (−2.5 L/min) and HR (−30 bpm). The persistent peak exercise HR deficit across 2 to 12 years post‐transplant suggests that functionally meaningful sympathetic reinnervation of the cardiac allograft either does not reliably occur in PHTR recipients or, when present, is insufficient to restore chronotropic reserve during maximal exercise. This interpretation is supported by prior evidence demonstrating that PHTR recipients without sympathetic reinnervation exhibit reduced exercise tolerance and increased risk of mortality and retransplantation [2]. Only two included studies reporting VO2peak also measured peak stroke volume, with divergent findings [4, 10]; therefore, future studies should systematically assess peak stroke volume (and its determinants) to fully characterize the central hemodynamic limitations to exercise. Regardless, these results underscore the need for interventions targeting persistent VO2peak and/or chronotropic limitations in PHTR recipients, with exercise training appearing most promising. Several limitations warrant consideration. First, the cross‐sectional design of included studies precludes longitudinal assessment of individual trajectories in VO2peak or central hemodynamics over time. Second, substantial between study heterogeneity in VO2peak was not fully explained by age or time post‐transplant and likely reflects unmeasured clinical differences such as pre‐transplant heart failure etiology, immunosuppressive regimen, history of rejection, or exercise testing modality. Third, the small number of studies reporting peak exercise CO and the absence of O2 extraction data limit our ability to fully partition central versus peripheral contributions to the observed VO2peak deficit. Conclusion PHTR recipients demonstrate a marked impairment in cardiorespiratory fitness compared with age‐matched CON. This deficit appears primarily driven by central hemodynamic limitations, specifically persistent cardiac allograft sympathetic denervation and reduced peak exercise CO, and does not attenuate with increasing time post‐transplant. Clinically, these findings support routine assessment of VO2peak and peak exercise HR and CO during follow up to identify patients with clinically meaningful limitations and to target therapies such as structured exercise training and individualized cardiac rehabilitation. Future prospective studies employing comprehensive Fick equation assessments are needed to delineate the central and peripheral mechanisms underlying impaired VO2peak across the PHTR survivorship continuum and to evaluate whether targeted interventions improve VO2peak and long‐term health outcomes in this population. Author Contributions Nadeen Wu: writing – original draft, investigation, data curation Stephen J. Foulkes: conceptualization, writing – review and editing Nathan R. Weeldreyer: writing – review and editing, supervision, investigation, data curation Calvin Kruger: writing – review and editing, data curation Corey R. Tomczak: Writing – Review and Editing Michael Khoury: Writing – Review and Editing Jennifer L. Conway: Writing – Review and Editing Mark J. Haykowsky: Writing – original draft, Conceptualization, Supervision, Formal Analysis, Visualization. Funding None Ethics Statement Not applicable. Consent for Publication Not applicable. Conflicts of Interest The authors declare no conflicts of interest.